NCT05089721 is a clinical trial in Uterine Bleeding, sponsored by Gazi University.

Who is sponsoring NCT05089721?

NCT05089721 is sponsored by Gazi University.

What condition does NCT05089721 study?

NCT05089721 studies Uterine Bleeding, Atony, Uterine, Cesarean Section Complications.

Is NCT05089721 still recruiting?

NCT05089721 is currently status unknown. Last updated 3 January 2025.

Last reviewed 2025-01-03 · How we verify

NCT05089721

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Questionnaire for Obstetricians and Anesthesiologist

Status unknown Last updated 3 January 2025

What this trial tests

trial in Uterine Bleeding in 200 participants. Status unknown.

Timeline

21 May 2022

Primary endpoint
21 September 2022

21 February 2025

Quick facts

Lead sponsor	Gazi University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	200
Start date	21 May 2022
Primary completion	21 September 2022
Estimated completion	21 February 2025
Sites	1 location across Turkey (Türkiye)

Conditions studied

Uterine Bleeding — all drugs for Uterine Bleeding →
Atony, Uterine — all drugs for Atony, Uterine →
Cesarean Section Complications — all drugs for Cesarean Section Complications →

Sponsor

Gazi University

Who can join

Eligibility, any sex, with Uterine Bleeding or Atony, Uterine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The research was planned as a face-to-face survey evaluation. The questionnaire will be applied to obstetricians and anesthesiologists working in public and private hospitals. The universe of the research will be selected by simple random sampling method, and the total number of people who will participate is planned to be 200, approximately 100 from each of the two branches. Our survey consists of 5 parts structurally. Demographic data, rate of cesarean section and postpartum hemorrhage, uterotonic agent preferences in low/high risk cesarean section surgeries, the preference for second-line uterotonic agents, and the dose preferences of uterotonic agents.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Snapshot Survey of Uterotonic Administration Practice During Cesarean Section: Is There a Difference Between the Attitudes of Obstetricians and Anesthesiologists?
Camgoz Eryilmaz N, Erel S, Gunaydin DB. · · 2025 · PMID 40005370 · DOI 10.3390/medicina61020253

Verify or expand the search:

Other recruiting trials for Uterine Bleeding

Currently open trials in the same condition.

NCT05224726 — Platelet Rich Plasma for Uterine Scar · NA · recruiting
NCT06953076 — Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study · recruiting
NCT06308172 — Impact of Single- Versus Double-layer Hysterotomy Closure on Cesarean Niche Development: a Randomized Controlled Trial · NA · recruiting

Other Gazi University trials

Trials by the same sponsor.

NCT07500857 — Gamification in Stoma Care Education for Nursing Students · NA · not yet recruiting
NCT07471737 — Patient Safety and Medical Errors in Nursing Education: Learning by Doing and Experiencing With Simulated Patients · NA · not yet recruiting
NCT07440563 — Auricular Vagus Nerve Stimulation Combined With Rehabilitation in Parkinson's Disease · NA · enrolling by invitation
NCT07496398 — Median and Ulnar Nerve Function in Tattoo Artists · recruiting
NCT07471386 — Adjunctive Keratinized Mucosa Augmentation in Peri-Implantitis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05089721 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gazi University
Last refreshed: 3 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05089721.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing